probiome Sign in
← Conditions Immune systemMetabolism and nutrition Genus-level

Graves' eye disease

Compared within 1 study that had both: 30 people with Graves' eye disease and 29 healthy people. 1 genus is less common in people with Graves' eye disease, and none more common.

A difference is an association: it doesn’t mean these genera cause, prevent or treat Graves' eye disease. GMrepo reports this group at the genus level only, so these are genera, not species.

Searching opens both lists and shows only matching rows.

Less common in Graves' eye disease · 1

Strongest first, then the biggest gap · Each figure is 10 people Strongest first · Each figure is 10 people
  1. Atopobium genus in 1 study Healthy 90% Graves' eye disease 53%

More common in Graves' eye disease · 0

Strongest first, then the biggest gap · Each figure is 10 people Strongest first · Each figure is 10 people

None compared.

Where these numbers come from

Studies
Only GMrepo projects that had people with the condition and healthy people, 10 or more of each. Numbers come from those studies, never from pooling.Sampled in China.
How common
The share of people whose sample has any of it, in the people with the condition and in the healthy people of those same studies. Tested within studies (Cochran–Mantel–Haenszel, corrected for testing many microbes); a difference counts when it is clear and meaningful (Cohen’s h of 0.2 or more).
Strength word
Counted by code from how many studies point the same way: Seen again and again (3 or more, none clearly the other way), Seen more than once (2, the majority), Seen once (1, listed last). Where studies disagree, a row isn’t listed.
Each study
Tap a row for every study’s own numbers, and for how much carriers have.
Analysis
Our analysis of GMrepo data. GMrepo on Data sources · Read the rules

Also compared · 67 genera

Compared within studies that had both, but not listed above.

No meaningful difference · 67
PubMed · human studies and reviews first

Recent research

All research on it
  1. Archives of biochemistry and biophysics · 2025
    Faecalibacterium prausnitzii alleviates Graves' orbitopathy by modulating short-chain fatty acid (SCFA) metabolism and inhibiting orbital fibrosis and adipogenesis.
    PubMed ↗
  2. Observational Frontiers in endocrinology · 2024
    Exploring gut microbiota and metabolite alterations in patients with thyroid-associated ophthalmopathy using high-throughput sequencing and untargeted metabolomics.
    PubMed ↗
  3. Review Frontiers in cellular and infection microbiology · 2021
    The Role of the Microbiota in Graves' Disease and Graves' Orbitopathy.
    PubMed ↗

Source: PubMed, U.S. National Library of Medicine · 3 linked papers, last 10 years